Mucolipidosis IV consists of one complementation group

AUTOR(ES)

Goldin, Ehud

FONTE

The National Academy of Sciences

RESUMO

Mucolipidosis IV (MLIV) is an autosomal recessive disorder of unknown etiology characterized by severe visual impairment and psychomotor retardation. Recently, there has been considerable interest in positional cloning of the MLIV gene. It is unknown whether MLIV is a genetically homogenous disorder. In this paper, we present experiments that determined whether the MLIV phenotype in fibroblasts could be corrected by fusing normal cells to MLIV cells and fusing fibroblasts from pairs of patients. All of our MLIV patients fulfilled several diagnostic criteria that we developed. In addition, we found high sensitivity to chloroquine in cultured fibroblasts from MLIV patients. We found that normal cells corrected the MLIV phenotype. Fusion products of normal and MLIV fibroblasts, but not MLIV fibroblasts themselves, were relatively protected against chloroquine selection. In addition, 74% of the normal-to-patient fusion products had reduced levels or total loss of MLIV characteristic autofluorescence. However, there was no complementation of the phenotype in fibroblast cultures from any of our MLIV patients, including those of non-Jewish ancestry. In fusion products of MLIV cultures from 24 patients, 90–100% of the cells remained autofluorescent. These results indicate that all of our known MLIV patients, regardless of ancestry or severity of the developmental defect, have a single mutated gene.

Documentos Relacionados

• Constitutive achlorhydria in mucolipidosis type IV
• Transcription and Replication of Vesicular Stomatitis Virus: Effects of Temperature-Sensitive Mutations in Complementation Group IV
• Abnormal transport along the lysosomal pathway in Mucolipidosis, type IV disease
• Carrier Screening for Mucolipidosis Type IV in the American Ashkenazi Jewish Population
• Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV.